| Attribute |
Value |
| 52 Week Change |
3.1027026 |
| Address1 |
1,405 Research Boulevard |
| Address2 |
Suite 125 |
| All Time High |
530.0 |
| All Time Low |
5.0 |
| Ask |
38.59 |
| Ask Size |
2 |
| Audit Risk |
8 |
| Average Analyst Rating |
2.0 - Buy |
| Average Daily Volume10 Day |
36,180 |
| Average Daily Volume3 Month |
305,504 |
| Average Volume |
305,504 |
| Average Volume10Days |
36,180 |
| Beta |
-0.102 |
| Bid |
23.4 |
| Bid Size |
2 |
| Board Risk |
8 |
| Book Value |
18.241 |
| City |
Rockville |
| Compensation Risk |
8 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
30.36 |
| Current Ratio |
5.059 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
32.5 |
| Day Low |
29.555 |
| Debt To Equity |
8.116 |
| Display Name |
Sensei Biotherapeutics |
| Earnings Timestamp End |
1,754,656,200 |
| Earnings Timestamp Start |
1,754,310,600 |
| Ebitda |
-22,149,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.949 |
| Enterprise Value |
21,015,932 |
| Eps Forward |
-1.12 |
| Eps Trailing Twelve Months |
-16.72 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
27.8704 |
| Fifty Day Average Change |
2.4896011 |
| Fifty Day Average Change Percent |
0.08932779 |
| Fifty Two Week Change Percent |
310.27026 |
| Fifty Two Week High |
36.76 |
| Fifty Two Week High Change |
-6.3999977 |
| Fifty Two Week High Change Percent |
-0.17410223 |
| Fifty Two Week Low |
5.26 |
| Fifty Two Week Low Change |
25.1 |
| Fifty Two Week Low Change Percent |
4.771863 |
| Fifty Two Week Range |
5.26 - 36.76 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,612,449,000,000 |
| Float Shares |
810,857 |
| Forward Eps |
-1.12 |
| Forward P E |
-27.107143 |
| Free Cashflow |
-12,611,000 |
| Full Exchange Name |
NasdaqCM |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,775,001,600 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.3019 |
| Held Percent Institutions |
0.13062 |
| Implied Shares Outstanding |
1,340,281 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-02-04 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,750,118,400 |
| Last Split Factor |
1:20 |
| Long Business Summary |
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. |
| Long Name |
Sensei Biotherapeutics, Inc. |
| Market |
us_market |
| Market Cap |
40,690,932 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_732397 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
-21,085,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
40,248,638 |
| Number Of Analyst Opinions |
1 |
| Open |
30.84 |
| Operating Cashflow |
-20,453,000 |
| Operating Margins |
0.0 |
| Overall Risk |
8 |
| Payout Ratio |
0.0 |
| Phone |
240 243 8000 |
| Pre Market Change |
1.2600002 |
| Pre Market Change Percent |
4.1501985 |
| Pre Market Price |
31.62 |
| Pre Market Time |
1,776,844,812 |
| Previous Close |
31.39 |
| Price Hint |
2 |
| Price To Book |
1.6643826 |
| Profit Margins |
0.0 |
| Quick Ratio |
4.983 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.0 |
| Region |
US |
| Regular Market Change |
-1.03 |
| Regular Market Change Percent |
-3.2813 |
| Regular Market Day High |
32.5 |
| Regular Market Day Low |
29.555 |
| Regular Market Day Range |
29.555 - 32.5 |
| Regular Market Open |
30.84 |
| Regular Market Previous Close |
31.39 |
| Regular Market Price |
30.36 |
| Regular Market Time |
1,776,801,600 |
| Regular Market Volume |
24,359 |
| Return On Assets |
-0.40813 |
| Return On Equity |
-0.74011004 |
| Sand P52 Week Change |
0.3140242 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
8 |
| Shares Outstanding |
1,340,281 |
| Shares Percent Shares Out |
0.6443 |
| Shares Short |
863,539 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
538,588 |
| Short Name |
Sensei Biotherapeutics, Inc. |
| Short Percent Of Float |
0.9321 |
| Short Ratio |
7.78 |
| Source Interval |
15 |
| State |
MD |
| Symbol |
SNSE |
| Target High Price |
50.0 |
| Target Low Price |
50.0 |
| Target Mean Price |
50.0 |
| Target Median Price |
50.0 |
| Total Cash |
21,184,000 |
| Total Cash Per Share |
15.806 |
| Total Debt |
1,509,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-16.72 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
13.8614 |
| Two Hundred Day Average Change |
16.4986 |
| Two Hundred Day Average Change Percent |
1.1902549 |
| Type Disp |
Equity |
| Volume |
24,359 |
| Website |
https://www.senseibio.com |
| Zip |
20,850 |